InvestorPlace - Stock Market News, Stock Advice & Trading Tips
MNPR stock results show that Monopar Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
The post MNPR Stock Earnings: Monopar Therapeutics Beats EPS for Q4 2023 appeared first on InvestorPlace.
More From InvestorPlace